Neurology Alert – November 1, 2012
November 1, 2012
View Issues
-
Controlling Diabetic Neuropathic Pain
Three common medications amitriptyline, duloxetine, and pregabalin all appear equally efficacious in treating neuropathic pain from diabetic neuropathy. -
Should Patients with Multiple Sclerosis Avoid IVF?
Multiple sclerosis (MS) relapse rates were found to increase post in vitro fertilization (IVF) in a small population of MS patients. The risk for relapse was highest in the first 3 months post-IVF. -
BG-12: New Oral Medication for Relapsing-remitting MS
Two recently reported Phase 3 trials for BG-12 demonstrated efficacy and safety in the treatment of relapsing-remitting multiple sclerosis. -
Stroke Alert: A Review of Current Clinical Stroke Literature
A Simple Score Can Predict Outcome after Ischemic Stroke; Mismatch Between Perfusion and Diffusion on MRI Can Identify Good Candidates for Endovascular Reperfusion Therapy; Cerebral Microbleeds May Be Associated with Elevated Vascular Endothelial Growth Factor -
Predictors of Outcome in SCN1A-positive Dravet Syndrome
Early seizures and EEG abnormalities as well as status epilepticus predicts worse outcome in SCN1A-positve Dravet syndrome in this new, large cohort of patients. -
Antibodies to Clustered Acetylcholine Receptor in Myasthenia Gravis
Up to 50% of patients with seronegative ocular myasthenia gravis have antibodies to clustered acetylcholine receptor antibodies that can fix complement and passively transfer disease to experimental mice. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Do Benzodiazepines Cause Dementia in the Elderly?
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.